NCT04618913View on ClinicalTrials.gov

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

NeoplasmsEmbolism

Interventions

DRUG

Apixaban

Anticoagulant

DRUG

Rivaroxaban

Anticoagulant

DRUG

Edoxaban

Edoxaban

DRUG

Dabigatran

Dabigatran

DRUG

VKA

Vitamin K antagonist

DRUG

LMWH

Low Molecular Weight Heparin

Trial Locations (1)

Unknown

Pfizer Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY